ORCHID PHARMA
|
ORCHID PHARMA Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹41 Cr | ₹41 Cr | ₹41 Cr | ₹41 Cr | ₹89 Cr |
Equity - Authorised | ₹150 Cr | ₹150 Cr | ₹150 Cr | ₹150 Cr | ₹150 Cr |
Equity - Issued | ₹41 Cr | ₹41 Cr | ₹41 Cr | ₹41 Cr | ₹89 Cr |
Equity Paid Up | ₹41 Cr | ₹41 Cr | ₹41 Cr | ₹41 Cr | ₹89 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹648 Cr | ₹607 Cr | ₹612 Cr | ₹725 Cr | ₹-793 Cr |
Securities Premium | ₹464 Cr | ₹464 Cr | ₹464 Cr | ₹464 Cr | ₹464 Cr |
Capital Reserves | ₹1,682 Cr | ₹1,682 Cr | ₹1,682 Cr | ₹1,682 Cr | ₹99 Cr |
Profit & Loss Account Balance | ₹-2,268 Cr | ₹-2,314 Cr | ₹-2,314 Cr | ₹-1,914 Cr | ₹-1,870 Cr |
General Reserves | ₹559 Cr | ₹559 Cr | ₹559 Cr | ₹559 Cr | ₹559 Cr |
Other Reserves | ₹211 Cr | ₹216 Cr | ₹221 Cr | ₹-66 Cr | ₹-45 Cr |
Reserve excluding Revaluation Reserve | ₹648 Cr | ₹607 Cr | ₹612 Cr | ₹725 Cr | ₹-793 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹689 Cr | ₹647 Cr | ₹653 Cr | ₹766 Cr | ₹-704 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹40 Cr | ₹111 Cr | ₹342 Cr | ₹430 Cr | ₹1,425 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹82 Cr | ₹148 Cr | ₹364 Cr | ₹492 Cr | ₹2,708 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-42 Cr | ₹-37 Cr | ₹-22 Cr | ₹-62 Cr | ₹-1,284 Cr |
Unsecured Loans | ₹109 Cr | ₹97 Cr | ₹86 Cr | ₹74 Cr | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | ₹109 Cr | ₹97 Cr | ₹86 Cr | ₹74 Cr | - |
Deferred Tax Assets / Liabilities | ₹3.23 Cr | ₹3.23 Cr | ₹3.23 Cr | ₹3.23 Cr | ₹3.23 Cr |
Deferred Tax Assets | ₹86 Cr | ₹83 Cr | ₹149 Cr | ₹197 Cr | ₹240 Cr |
Deferred Tax Liability | ₹89 Cr | ₹86 Cr | ₹153 Cr | ₹201 Cr | ₹244 Cr |
Other Long Term Liabilities | - | - | - | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹13 Cr | ₹11 Cr | ₹12 Cr | ₹12 Cr | ₹7.70 Cr |
Total Non-Current Liabilities | ₹165 Cr | ₹222 Cr | ₹442 Cr | ₹519 Cr | ₹1,436 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹182 Cr | ₹168 Cr | ₹110 Cr | ₹102 Cr | ₹302 Cr |
Sundry Creditors | ₹182 Cr | ₹168 Cr | ₹110 Cr | ₹102 Cr | ₹302 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹46 Cr | ₹47 Cr | ₹26 Cr | ₹70 Cr | ₹1,344 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | - | - | - | - | - |
Interest Accrued But Not Due | - | - | - | - | ₹216 Cr |
Share Application Money | - | - | - | - | ₹0.05 Cr |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹46 Cr | ₹47 Cr | ₹26 Cr | ₹70 Cr | ₹1,128 Cr |
Short Term Borrowings | ₹141 Cr | ₹23 Cr | ₹2.84 Cr | - | ₹695 Cr |
Secured ST Loans repayable on Demands | ₹141 Cr | ₹23 Cr | ₹2.84 Cr | - | ₹557 Cr |
Working Capital Loans- Sec | ₹141 Cr | ₹23 Cr | ₹2.84 Cr | - | ₹557 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-141 Cr | ₹-23 Cr | ₹-2.84 Cr | - | ₹-419 Cr |
Short Term Provisions | ₹3.49 Cr | ₹3.01 Cr | ₹3.52 Cr | ₹3.25 Cr | ₹3.63 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | - | - | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹3.49 Cr | ₹3.01 Cr | ₹3.52 Cr | ₹3.25 Cr | ₹3.63 Cr |
Total Current Liabilities | ₹372 Cr | ₹241 Cr | ₹142 Cr | ₹175 Cr | ₹2,346 Cr |
Total Liabilities | ₹1,225 Cr | ₹1,111 Cr | ₹1,237 Cr | ₹1,460 Cr | ₹3,077 Cr |
ASSETS | |||||
Gross Block | ₹1,221 Cr | ₹1,176 Cr | ₹1,176 Cr | ₹1,247 Cr | ₹1,520 Cr |
Less: Accumulated Depreciation | ₹647 Cr | ₹593 Cr | ₹506 Cr | ₹389 Cr | ₹263 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹573 Cr | ₹584 Cr | ₹670 Cr | ₹858 Cr | ₹1,256 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹46 Cr | ₹9.78 Cr | ₹7.43 Cr | ₹15 Cr | ₹264 Cr |
Non Current Investments | ₹44 Cr | ₹45 Cr | ₹0.40 Cr | ₹0.34 Cr | ₹0.47 Cr |
Long Term Investment | ₹44 Cr | ₹45 Cr | ₹0.40 Cr | ₹0.34 Cr | ₹0.47 Cr |
Quoted | ₹0.14 Cr | ₹0.09 Cr | ₹0.13 Cr | ₹0.06 Cr | ₹0.19 Cr |
Unquoted | ₹45 Cr | ₹46 Cr | ₹0.88 Cr | ₹0.88 Cr | ₹0.88 Cr |
Long Term Loans & Advances | ₹60 Cr | ₹74 Cr | ₹9.10 Cr | ₹6.70 Cr | ₹765 Cr |
Other Non Current Assets | - | ₹0.01 Cr | ₹0.01 Cr | - | ₹9.84 Cr |
Total Non-Current Assets | ₹724 Cr | ₹713 Cr | ₹687 Cr | ₹891 Cr | ₹2,310 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | ₹15 Cr | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | ₹15 Cr | - | - |
Inventories | ₹229 Cr | ₹173 Cr | ₹153 Cr | ₹142 Cr | ₹170 Cr |
Raw Materials | ₹76 Cr | ₹43 Cr | ₹37 Cr | ₹47 Cr | ₹48 Cr |
Work-in Progress | ₹77 Cr | ₹69 Cr | ₹56 Cr | ₹42 Cr | ₹50 Cr |
Finished Goods | ₹68 Cr | ₹55 Cr | ₹54 Cr | ₹43 Cr | ₹43 Cr |
Packing Materials | ₹3.99 Cr | ₹2.36 Cr | ₹3.47 Cr | ₹3.37 Cr | ₹6.79 Cr |
Stores Ā and Spare | ₹3.46 Cr | ₹3.54 Cr | ₹3.45 Cr | ₹5.45 Cr | ₹20 Cr |
Other Inventory | - | - | - | ₹0.91 Cr | ₹1.59 Cr |
Sundry Debtors | ₹215 Cr | ₹171 Cr | ₹136 Cr | ₹68 Cr | ₹120 Cr |
Debtors more than Six months | - | ₹13 Cr | ₹6.33 Cr | - | - |
Debtors Others | ₹259 Cr | ₹200 Cr | ₹197 Cr | ₹138 Cr | ₹161 Cr |
Cash and Bank | ₹31 Cr | ₹8.06 Cr | ₹20 Cr | ₹174 Cr | ₹326 Cr |
Cash in hand | ₹0.01 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.02 Cr | ₹0.01 Cr |
Balances at Bank | ₹31 Cr | ₹8.03 Cr | ₹20 Cr | ₹174 Cr | ₹326 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹3.95 Cr | ₹13 Cr | ₹130 Cr | ₹22 Cr | ₹12 Cr |
Interest accrued on Investments | ₹0.16 Cr | ₹0.00 Cr | ₹0.07 Cr | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | ₹0.01 Cr | ₹2.37 Cr |
Prepaid Expenses | ₹3.79 Cr | ₹7.12 Cr | ₹2.57 Cr | ₹13 Cr | ₹9.64 Cr |
Other current_assets | - | ₹5.89 Cr | ₹128 Cr | ₹8.99 Cr | - |
Short Term Loans and Advances | ₹23 Cr | ₹20 Cr | ₹96 Cr | ₹164 Cr | ₹140 Cr |
Advances recoverable in cash or in kind | ₹9.64 Cr | ₹3.47 Cr | ₹6.10 Cr | ₹33 Cr | ₹154 Cr |
Advance income tax and TDS | ₹0.95 Cr | ₹0.32 Cr | ₹54 Cr | ₹59 Cr | ₹70 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹12 Cr | ₹16 Cr | ₹35 Cr | ₹72 Cr | ₹-83 Cr |
Total Current Assets | ₹501 Cr | ₹384 Cr | ₹550 Cr | ₹569 Cr | ₹767 Cr |
Net Current Assets (Including Current Investments) | ₹129 Cr | ₹144 Cr | ₹408 Cr | ₹394 Cr | ₹-1,578 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹1,225 Cr | ₹1,111 Cr | ₹1,237 Cr | ₹1,460 Cr | ₹3,077 Cr |
Contingent Liabilities | ₹42 Cr | ₹43 Cr | ₹45 Cr | - | ₹143 Cr |
Total Debt | ₹331 Cr | ₹268 Cr | ₹453 Cr | ₹566 Cr | ₹3,230 Cr |
Book Value | 168.72 | 158.61 | 159.96 | 187.67 | -79.14 |
Adjusted Book Value | 168.72 | 158.61 | 159.96 | 187.67 | -79.14 |
Compare Balance Sheet of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹5,287.2 Cr | -3.9% | -6% | 172.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | -3.9% |
-6% |
172.7% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses